|
[SGLTi + previously taken RAAS blocker] Clinical Trials
1 actively recruiting trial
No change since May 2026
Pipeline
Phase 2: 1
Top Sponsors
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation1
Indications
- LVDD1
- HFpEF1
- Myocardial Fibrosis1
- Heart Disease1
Other1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.